Ampersand Capital Partners invests in Julius Clinical Research
Ampersand Capital Partners, based in Wellesley, Massachusetts, announced its acquisition of Julius Clinical Research. According to data captured in the LevinPro HC database, this acquisition is the 40th contract research organization (CRO) transaction of the year. Based in the Netherlands, Julius Clinical Research is a leading academic clinical CRO that provides clinical trial services and real-world evidence studies to biopharma sponsors. Founded in 1988, Ampersand is a middle-market private equity firm with more than $3 billion of assets under management dedicated to investments in the healthcare sector. This transaction will allow Julius Clinical Research to expand... Read More »
ArchiMed Expands Clinical Research Organization Portfolio
ArchiMed announced it has acquired two clinical contract research organizations (CRO): Port Jefferson, New York-based Symbio, LLC and Proinnovera GmbH, in Munster, Germany. According to data captured in the LevinPro HC database, this transaction marks the 37th CRO acquisition of the year. Between January 1, 2022, and November 17, 2022, there were also 37 CRO transactions announced, showing a healthy and stable CRO market. Symbio offers expertise in proof-of-concept, medical devices and Phase 1 – Phase 4 clinical studies and has completed more than 200 clinical studies to date. Proinnovera was founded in 1997. It serves more than 100,000 patients across more than 4,500... Read More »
PE-Backed Everest Clinical Research Acquires August Research
Everest Clinical Research, a portfolio company of Washington, D.C.-based private equity firm Arlington Capital Partners, announced on November 7 that it acquired Sofia, Bulgaria-based August Research. August Research is a contract research organization (CRO) that provides clinical trial services (CTS) and pharmacovigilance services to a variety of pharmaceutical and biotechnology clients. The CRO has worked on more than 120 projects for Phase I-IV clinical trials across multiple therapeutic areas including cardiovascular, infectious disease, oncology and rare disease. Everest Clinical Research is a full-service CRO providing a range of expertise-based clinical research services... Read More »
Resolian Acquires Denali Medpharma
Resolian, a portfolio company of Ampersand Capital Partners, announced that it acquired Denali Medpharma. Denali Medpharma is a Chinese bioanalytical contract research organization (CRO). It is well known as the industry leader in China in the bioanalysis of oligonucleotide drugs and mRNA vaccines, liposomal drug, ultra-sensitive assays for inhalation drugs and biomarker assays. Resolian (formerly Alliance Pharma Inc. and Drug Development Solutions Ltd.) is a CRO that specializes in advanced bioanalytical research services for small and large molecule drugs. It also specializes in drug metabolism studies to support pharmaceutical and biotechnology companies’ drug... Read More »
MITRO Biotech Merges With XINGIMAGING
MITRO Biotech Co., Ltd and XingImaging, LLC announced a definitive agreement to merge. According to data captured in the LevinPro HC database, this transaction marks the 34th contract research organization (CRO) transaction of the year. XingImaging is a clinical PET imaging service and CRO that specializes in radiotracer production through positron emission tomography acquisition to evaluate. The CRO supports the development of treatments for neurodegenerative disorders such as Alzheimer and Parkinson disease, oncology and other disease pathologies. It has a location in Madison, Connecticut. MITRO Biotech is a molecular imaging CRO company based in Nanjing, China. The... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
